Advertisement

Topics

NAM Asia Hong Kong Co., Ltd. Company Profile

15:21 EDT 18th September 2018 | BioPortfolio

CEO Teppei Nakano graduated from Keio University School of Medicine in 2017. We have been adopting IPA unexplored projects by the Ministry of Economy, Trade and Industry, which represent a large number of representatives of IT companies representing Japan, twice in 2016 and 2017, independent businesses that have been adopted by unexplored This is the NAM project of this time.


News Articles [498 Associated News Articles listed on BioPortfolio]

Profectus and MediSun launch Asian joint venture

The new Hong Kong company will focus on preventive and therapeutic vaccines for Hong Kong, China and the rest of Asia.

Hong Kong scrambles for talent in battle for Nasdaq's biotech crown

HONG KONG (Reuters) - When Hong Kong unveiled plans last year to encourage biotech companies to list in the city by loosening listing rules, the financial industry and investors cheered.

Hong Kong election gauges city's stomach for defying Beijing

HONG KONG (AP) — Hong Kong residents voted Sunday in by-elections that give opposition supporters the chance to recapture lost ground in a contest measuring voters' appetite for democracy in the...

Hong Kong democracy movement loses ground in key by-election

HONG KONG (AP) — Hong Kong pro-democracy candidates won back only two of four seats in a crucial by-election in the semiautonomous Chinese region, final results showed Monday.

Hansoh Pharma Plans Hong Kong IPO that Could Raise $1-$3 Billion

Hansoh, a China pharma based in Lianyungang, Jiangsu province, has applied to stage an IPO on the Hong Kong exchange. Unlike most companies seeking Hong Kong IPOs, Hansoh is both profitable and establ...

Grail, a US-Hong Kong Diagnostics Company, May Stage $500 Million Hong Kong IPO

Grail, a US spinout from Illumina that is developing blood-based cancer detection tests, is considering a $500 million Hong Kong IPO. Last year, Grail completed a $900 million Series B fundraising, th...

Hong Kong scientists say new research points to universal antibody drug for HIV

HONG KONG (Reuters) - A team of AIDS researchers in Hong Kong says its new research, tested on mice, indicates a functional cure for HIV, the virus that causes AIDS, eventually leading to a new antibo...

Premia Partners launches world's first Asia Innovative Technology and Emerging ASEAN Titans ...

HONG KONG, Aug. 5, 2018 /PRNewswire/ -- Premia Partners, the Hong Kong-based investment firm that focuses on ETFs and smart beta solutions, announces the launch Read more...

PubMed Articles [412 Associated PubMed Articles listed on BioPortfolio]

Risk Factors of Early Childhood Caries among Young Children in Hong Kong: A Cross-Sectional Study.

Early childhood caries (ECC) was prevalent in Hong Kong. Children with ECC risk should be identified early for prevention. This study aimed to identify common risk factors of ECC in Hong Kong 3-year-o...

Methylmercury levels in commonly consumed fish and methylmercury exposure of children and women of childbearing age in Hong Kong, a high fish consumption community.

Despite high fish consumption levels of Hong Kong residents, little is known about the MeHg exposure levels of Hong Kong high-risk populations (i.e. young children and women of childbearing age).

Hypothalamus and pituitary transcriptome profiling of male and female Hong Kong grouper (Epinephelus akaara).

Hong Kong grouper (Epinephelus akaara) is an important commercially cultured marine fish in Asia, and a protogynous hermaphrodite with the "diandry" pattern. In order to explore the gene expression pa...

Maternal knowledge and attitudes to universal newborn hearing screening: Reviewing an established program.

To facilitate early diagnosis of infants with hearing loss, a universal newborn hearing screening program (UNHS) has been implemented in Hong Kong's public hospitals for over a decade. However, there ...

Seasonal influenza vaccine effectiveness at primary care level, Hong Kong SAR, 2017/2018 winter.

The 2017/18 winter influenza season in Hong Kong SAR started in early January 2018, predominated by influenza B/Yamagata. We collaborated with private medical practitioners of our sentinel surveillanc...

Clinical Trials [509 Associated Clinical Trials listed on BioPortfolio]

Hong Kong Spinocerebellar Ataxias Registry

Spinocerebellar ataxias (SCA) 1, 2, 3 and 6 are the most common, autosomal dominantly inherited cerebellar degenerations. And in the Chinese population, the most common SCA is SCA3 and the...

A Survey on the Rate of Glucose Intolerance in Hong Kong Chinese

Hypothesis: There is a high rate of glucose intolerance among Hong Kong Chinese. The investigators plan to screen Hong Kong Chinese from the community with oral glucose tolerance test (OG...

Physical Activity and Dietary Attitudes and Behavioural Patterns in the Hong Kong Community

The health benefits of regular physical activity and a healthy diet are well established in literature. Regular physical activity and a healthy diet may reduce the risk of certain non-comm...

Gut Microbiota in the Healthy Population, Inflammatory Bowel Disease Patients, and Their Relatives

The aim of this study is to compare the gut microbiota in Chinese patients with Inflammatory Bowel Disease (IBD) in Hong Kong with that of healthy controls, compare the gut microbiota in I...

Edoxaban Treatment in Routine Clinical Practice for Patients With Non-valvular Atrial Fibrillation (ETNA-AF-Hong Kong)

In order to understand the risks and benefits of edoxaban use in a real-world clinical setting in the NVAF indication, Daiichi-Sankyo Hong Kong proposed this non-interventional study (NIS)...

Companies [671 Associated Companies listed on BioPortfolio]

Hong Kong Institute of Biotechnology Limited

The Hong Kong Institute of Biotechnology Limited (HKIB) is a Company Limited by Guarantee and is wholly controlled by the Council of the Chinese University of Hong Kong. It is located on the waterfron...

Hong Kong Sanatorium & Hospital, Ltd.

The Hong Kong Sanatorium & Hospital, with over 400 beds is a general hospital owned by Hong Kong Sanatorium & Hospital Limited, a private sector enterprise, celebrated its 80th Anniversary in 2002. Th...

The SHPHK

Motto"To promote, improve and assist the advancement of hospital pharmacy service"HistoryIn the 1980's, Hong Kong already had two pharmacy professional bodies, namely the Pharmaceutical Society (PS) o...

i-CABLE Communications Limited

CABLE Communications Limited was incorporated under the laws of Hong Kong in May 1999 and was listed on both The Stock Exchange of Hong Kong Limited and the Nasdaq Stock Market in the U.S. on November...

Johnson Electric

The Johnson Electric Group is one of the world’s largest providers of motion systems and components for automotive applications, domestic equipment, office equipment, industr...

More Information about "NAM Asia Hong Kong Co., Ltd." on BioPortfolio

We have published hundreds of NAM Asia Hong Kong Co., Ltd. news stories on BioPortfolio along with dozens of NAM Asia Hong Kong Co., Ltd. Clinical Trials and PubMed Articles about NAM Asia Hong Kong Co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NAM Asia Hong Kong Co., Ltd. Companies in our database. You can also find out about relevant NAM Asia Hong Kong Co., Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record